Article

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2

2021-05-19

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 160 million infections and more than 3 million deaths worldwide. While effective vaccines are currently being deployed, the adaptive immune determinants which promote viral clearance and confer protection remain poorly defined. Using mouse models of SARS-CoV-2, we demonstrate that both humoral and cellular adaptive immunity contribut...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b40b32b0-2d12-5f6e-b01a-33bfab415088
DOI: 10.1101/2021.05.19.444825

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2DOI 10.1101/2021.05.19.444825Read

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccinationSemantic proximity Read

A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of diseaseSemantic proximity Read

Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2Semantic proximity Read

Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.Semantic proximity Read

Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infectionSemantic proximity Read

Antibody response to SARS-CoV-2 infection in humans: a systematic reviewSemantic proximity Read

A Mouse Model of SARS-CoV-2-Driven Acute Maladaptive Responses and Chronic Systemic DiseasesSemantic proximity Read

Considerations of CD8+ T Cells for Optimized Vaccine Strategies Against Respiratory VirusesSemantic proximity Read

An intranasal vaccine durably protects against SARS-CoV-2 variants in miceSemantic proximity Read

SARS-CoV-2: The Interplay Between Evolution and Host Immunity.Semantic proximity Read

Nucleocapsid-specific humoral responses improve the control of SARS-CoV-2Semantic proximity Read

Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations.Semantic proximity Read